Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
GP(HK) Enters into A Few Agreements in the Field of Cancer Diagnostics and Treatment 2020-11-02 17:01
1